Inhibiting APOL1 to Treat Kidney Disease
Winfred W. Williams, Julie R. Ingelfinger
Abstract
This article describes the science behind a study on the use of inaxaplin in patients with focal segmental glomerulosclerosis who have two risk alleles of the gene APOL1.
Topics & Concepts
MedicineKidney diseaseKidneyIntensive care medicineMEDLINEDiseaseBioinformaticsInternal medicineLawPolitical scienceBiologyRenal Diseases and GlomerulopathiesCeliac Disease Research and ManagementCoagulation, Bradykinin, Polyphosphates, and Angioedema